| Entry |
|
|---|
| Name |
Methenamine (USP/INN);
Hexamine (JAN);
Hexamine (TN) |
|---|
| Formula |
C6H12N4
|
|---|
| Exact mass |
140.1062
|
|---|
| Mol weight |
140.1863
|
|---|
| Structure |
|
|---|
| Remark |
| Therapeutic category: | 2511 |
| Product (DG00635): | D00393<JP> D00855<US> |
|
|---|
| Efficacy |
Antibacterial, Antiseptic |
|---|
| Comment |
Adamantane derivative
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01X OTHER ANTIBACTERIALS
J01XX Other antibacterials
J01XX05 Methenamine
D00393 Methenamine (USP/INN) <JP>
USP drug classification [BR:br08302]
Antibacterials
Antibacterials, Other
Methenamine
D00393 Methenamine (USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
25 Urogenital and anal organ agents
251 Urinary organ agents
2511 Hexamines
D00393 Methenamine (USP/INN); Hexamine (JAN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Hexamine
D00393 Methenamine (USP/INN)
Antimicrobials [BR:br08307]
Antibacterials
Bactericidal action
Adamantane
D00393 Methenamine (USP/INN) <JP>
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 10
1 N1y N 26.0978 -17.4784
2 C1x C 27.1288 -18.1562
3 C1x C 25.6314 -18.6210
4 C1x C 24.8958 -18.1562
5 N1y N 27.1288 -19.4436
6 N1y N 25.6372 -20.8656
7 N1y N 24.9014 -19.4436
8 C1x C 27.4422 -21.4042
9 C1x C 26.0066 -20.1208
10 C1x C 23.9958 -21.1902
BOND 12
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 1
6 4 7 1
7 5 8 1
8 5 9 1
9 6 10 1
10 6 8 1
11 7 9 1
12 7 10 1
|
|---|
